Swiss pharmaceutical giant Novartis will watch "very carefully" how the reciprocal tariff policy proposed by the United ...

Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...

The Swiss pharma giant – which has its U.S. headquarters in East Hanover – said it aims to encourage football fans to "proactively manage their health." ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

The landscape of cancer treatment is undergoing a transformative shift as there is a rising demand for targeted, less toxic cancer medicines. The cancer field has seen significant advancements with ...

Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...

Pivotal Phase 3 OPERA-01 trial of palazestrant as a monotherapy in patients with 2/3L metastatic breast cancer on track for top-line data in ...

Swiss pharmaceutical giant Novartis (SIX:NOVN) is keeping a close eye on the U.S. tariff policy proposed by the Biden ...

Reports Q4 cash, cash equivalents, and marketable securities as of December 31 were $434.1M. “2024 was a productive year for Olema and we ...

American football’s elite National Football League (NFL) has brought in US medicine company Novartis as the property's ...

Last year, Novartis agreed to buy U.S.-based Mariana Oncology for $1 billion upfront to expand its portfolio of the drugs, ...